Atlas FDA

CONCERTO II/CONSULTA/MAXIMO II

FDA premarket approval P010031/S267 · decided 2011-08-12

Approval details

PMA number
P010031
Supplement
S267
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
CONCERTO II/CONSULTA/MAXIMO II
Applicant
Medtronic Cardiac Rhythm Disease Management
Date received
2011-07-15
Decision date
2011-08-12
Days to decision
28 days
Decision code
OK30
Advisory committee
Cardiovascular
Expedited review
No
Location
Mounds View, MN
Statement
MANUFACTURING SITE CHANGE OF SUPPLIER AND A MINOR CHANGE TO THE WIRE DRAWING PROCESS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.